# FDA recall D-0853-2026

> **Pfizer** · Class II · drug recall initiated 2026-09-04.

## Product

Dopamine HCl Inj., USP, 200 mg/5 mL (40 mg/mL), 5 mL Single-dose, 25 vials per tray, Rx only, Distributed by Hospira, Inc., Lake Forest, IL 60045 USA, Vial NDC 0409-5820-11, Carton NDC 0409-5820-01.

## Reason for recall

Lack of Assurance of Sterility

## Distribution

US Nationwide.

## Key facts

- **Recall number:** D-0853-2026
- **Recalling firm:** Pfizer
- **Classification:** Class II
- **Product type:** drug
- **Status:** Ongoing
- **Initiation date:** 2026-09-04
- **Report date:** 2026-09-23

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Manhattan, NY, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0853-2026

## Citation

> MORVS. FDA recall D-0853-2026. Retrieved 2026-10-20 from https://api.morvs.ai/recall/D-0853-2026. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*